Back to Search Start Over

Evaluation of apolipoprotein A5 variants: A cohort of patients with severe hypertriglyceridemia from Turkiye.

Authors :
Cakmak B
Yeral S
Ozcan B
Pariltay E
Ozgul S
Simsir IY
Hegele RA
Source :
Journal of clinical lipidology [J Clin Lipidol] 2024 May-Jun; Vol. 18 (3), pp. e423-e429. Date of Electronic Publication: 2023 Oct 12.
Publication Year :
2024

Abstract

Background: This study aims to show the clinical and biochemical features in patients with severe hypertriglyceridemia (HTG) associated with rare variants in the apolipoprotein A-V (APOA5) gene.<br />Materials and Methods: Demographics, blood lipid levels, body mass index (BMI) and APOA5 mutation subtypes were collected from the endocrinology clinic registry and analyzed for a retrospective cohort study of ten patients with severe HTG and APOA5 gene variants.<br />Results: Of the 10 cases, four were female, and six were male. The median age was 45.0 years (min-max: 21-60 years), the median triglyceride was 2429.5 mg/dL (27.5 mmol/L) (min-max: 1351-4087 mg/dL, 15.3-46.2 mmol/L), and the mean BMI was calculated as 30.4 ± 4.4 kg/m <superscript>2</superscript> (min-max: 24.9-41.0 kg/m <superscript>2</superscript> ). Four cases had diabetes mellitus (DM); two were on intensive insulin therapy, and two were on basal insulin therapy. The mean hemoglobin A1c was 9.2 ± 1.2 % (min-max: 8.3-11.0 %). Among the study group, eight different APOA5 gene mutations were detected. These variants were heterozygous in 2 patients and homozygous (bi-allelic) in 8 patients. One patient was homozygous for APOA5 p.Ser19Trp, a relatively common polymorphism that is a risk variant for HTG.<br />Conclusion: We report a cohort of patients with biallelic and single copy APOA5 variants, who were diagnosed later in life. Most had secondary factors, such as DM or obesity with increased BMI. Most rare APOA5 variants found in our patients were of uncertain significance. Our results add to the growing evidence that rare variants in certain candidate genes may predispose to developing HTG, together with secondary factors such as obesity. The genetic basis of HTG in many other patients is still unknown and remains the subject of further investigation.<br />Competing Interests: Declaration of Competing Interest The authors declare there is no conflict of interests.<br /> (Copyright © 2023. Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1933-2874
Volume :
18
Issue :
3
Database :
MEDLINE
Journal :
Journal of clinical lipidology
Publication Type :
Academic Journal
Accession number :
38627169
Full Text :
https://doi.org/10.1016/j.jacl.2023.09.015